Article 11 mins A Surge in Gene and Cell Therapies Raises Financing Questions Gene and cell therapies represent breakthrough advances in medicine, but they also have significant costs and potential risks for patients, employers, insurers, governments and manufacturers
4 First, observational studies that demonstrate the natural history after spine trauma of patients treated conservatively with the MRI performed in the later course
Correlation of sacropelvic geometry with disc degeneration in spondylolytic cadaver specimens
But when we looked at the data of User 22, we found a legitimate contradiction
(Simons et al., 2018) Multiplex format assay bead sets are functionalized with different glutathione-S-transferase-effector proteins at the surface of each set
There is not enough evidence to conclude that peptides are generally better than minoxidil